Industry: Pharmaceuticals, Biotechnology
Bioheart, Inc., based in Sunrise, Fla., is focused on the discovery, development and commercialization of cell-based therapies, and related devices, for the treatment of heart damage. Bioheart’s lead product candidate is MyoCell(tm), an innovative clinical therapy designed to populate regions of scar tissue within a patient’s heart with living muscle tissue for the purpose of improving cardiac function. Bioheart is currently testing MyoCell(tm) for treatment of severe, non-acute damage to the heart in patients in Class II or Class III heart failure according to the New York Heart Association heart failure classification system. ( www.bioheartinc.com )
Bioheart , Inc.
13794 NW 4Th Street Suite 212
Sunrise, Florida 33325
USA
Tel: (954) 835-1500
Fax: (954) 845-9976